METYRAPONE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for metyrapone and what is the scope of freedom to operate?

Metyrapone is the generic ingredient in one branded drug marketed by Hra Pharma and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for metyrapone. One supplier is listed for this compound.

Summary for METYRAPONE

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	109
Clinical Trials:	21
Patent Applications:	2,413
What excipients (inactive ingredients) are in METYRAPONE?	METYRAPONE excipients list
DailyMed Link:	METYRAPONE at DailyMed

Recent Clinical Trials for METYRAPONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Mayo Clinic	Phase 2
Biostat Sp. z o.o.	Phase 2
Maria Sklodowska-Curie National Research Institute of Oncology	Phase 2

See all METYRAPONE clinical trials

Pharmacology for METYRAPONE

Drug Class	Adrenal Steroid Synthesis Inhibitor
Mechanism of Action	Adrenal Steroid Synthesis Inhibitors

Medical Subject Heading (MeSH) Categories for METYRAPONE

Antimetabolites
Enzyme Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for METYRAPONE

V04CD	Tests for pituitary function
V04C	OTHER DIAGNOSTIC AGENTS
V04	DIAGNOSTIC AGENTS
V	Various

US Patents and Regulatory Information for METYRAPONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hra Pharma	METOPIRONE	metyrapone	CAPSULE;ORAL	012911-002	Aug 9, 1996		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hra Pharma	METOPIRONE	metyrapone	TABLET;ORAL	012911-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.